Medscape8d
Urine Test Strips Show Promise for Kidney Disease Screening
A urine test strip method using the semi-quantitative albumin-to-creatinine ratio can enhance the early detection of chronic ...
Acrivon Therapeutics to Host Corporate R&D Event to Provide AP3 Platform Capabilities and Clinical ACR-368 and ACR-2316 Program Updates
Event to be held via webcast on March 25, 2025 at 4:00 p.m. ETTo highlight differentiated drug discovery capabilities with its Generative ...
ACR-368 OncoSignature assay gains FDA breakthrough status
The ACR-368 OncoSignature assay is designed to identify ... with the ability to measure drug-specific effects on tumor cell protein signaling networks. Acrivon continues to develop its proprietary ...
Morningstar7d
Acrivon Therapeutics to Host Corporate R&D Event to Provide AP3 Platform Capabilities and Clinical ACR-368 and ACR-2316 Program Updates
The AP3 platform is engineered to measure compound-specific effects on the entire tumor cell protein signaling network ... advancing its lead candidate, ACR-368 (also known as prexasertib ...